{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T11:01:33Z","timestamp":1792839693877,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.drugalcdep.2016.05.012","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T17:45:34Z","timestamp":1464457534000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs"],"prefix":"10.1016","volume":"165","author":[{"given":"Amanda","family":"Weir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamish","family":"Innes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther J.","family":"Aspinall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen T.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Gunson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0005","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1093\/cid\/cit306","article-title":"Treatment of Hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis","author":"Aspinall","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0010","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/425361","article-title":"Infrequent reinfection after successful treatment for Hepatitis C virus infection in injection drug users","volume":"39","author":"Backmund","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2007.09.011","article-title":"A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus","volume":"93","author":"Currie","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000049487","article-title":"Treatment of chronic hepatitis C in injecting drug users: 5 years\u2019 follow-up","volume":"8","author":"Dalgard","year":"2007","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"Clinical practice guidelines: management of hepatitis C virus infection","volume":"60","author":"EASL","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0030","first-page":"1302","article-title":"Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam","volume":"24","author":"Grady","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0035","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/j.1440-1746.2010.06238.x","article-title":"Reinfection with hepatitis C virus following sustained virological response in injection drug users","volume":"25","author":"Grebely","year":"2010","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0040","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.24754","article-title":"Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection","volume":"55","author":"Grebely","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/infdis\/jit541","article-title":"Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection?","volume":"209","author":"Hara","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0050","series-title":"Hepatitis C In The UK. 2015 Report","author":"Health Protection Agency","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/jvh.12129","article-title":"Uptake of hepatitis C treatment among people who inject drugs attending needle and syringe programs in Australia, 1999\u20132011","volume":"21","author":"Iversen","year":"2014","journal-title":"J. Viral Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0060","first-page":"72","article-title":"The Scottish record linkage system","volume":"51","author":"Kendrick","year":"1993","journal-title":"Health Bull. Edinb."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/s10461-010-9813-x","article-title":"A plausible causal model of HAART-efficacy beliefs, HIV\/AIDS complacency, and HIV-acquisition risk behavior among young men who have sex with men","volume":"15","author":"Mackellar","year":"2011","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0070","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/OLQ.0b013e31820d5a77","article-title":"HIV\/AIDS complacency and HIV infection among young men who have sex with men, and the race-specific influence of underlying HAART beliefs","volume":"38","author":"Mackellar","year":"2011","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2013.03.008","article-title":"Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C","volume":"59","author":"Marco","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0080","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Reference Group to the UN on HIV and Injecting Drug Use, 2008. Global Epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0085","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/jech-2014-204451","article-title":"Rise in testing and diagnosis associated with Scotland\u2019s action plan on Hepatitis C and introduction of dried blood spot testing","volume":"68","author":"McLeod","year":"2014","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","article-title":"The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide","volume":"45","author":"Perz","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0100","unstructured":"R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http:\/\/www.R-project.org\/."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0105","series-title":"Hepatitis C Action Plan for Scotland: Phase I (September 2006\u2013April 2008)","author":"Scottish Government Health Department","year":"2006"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0110","series-title":"Hepatitis C Action Plan for Scotland: Phase II (May 2008\u2013March 2011)","author":"Scottish Government Health Department","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0115","series-title":"The Sexual Health and Blood Borne Virus Framework 2011\u20132015","author":"Scottish Government Health Department","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0120","series-title":"Management of Hepatitis C. Edinburgh. (SIGN Publication No. 133) [July 2013]","author":"Scottish Intercollegiate Guidelines Network (SIGN)","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0125","unstructured":"Scottish Medicines Consortium. Available from: https:\/\/www.scottishmedicines.org.uk\/SMC_Advice\/Advice\/1030_15_ledipasvir_sofosbuvir_Harvoni\/ledipasvir_sofosbuvir_Harvoni."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0130","first-page":"305","article-title":"Establishment of a database of diagnosed HCV-infected persons in Scotland","volume":"6","author":"Shaw","year":"2003","journal-title":"Commun. Dis. Public Health"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0135","unstructured":"StataCorp., 2005. Stata Statistical Software: Release 9. College Station, TX: StataCorp LP."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0140","series-title":"The Needle Exchange Surveillance Initiative (NESI): Prevalence Of HCV And Injecting Risk Behaviours Among People Who Inject Drugs Attending Injecting Equipment Provision Services In Scotland","author":"University of the West of Scotland","year":"2008"},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0145","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2015.06.032","article-title":"Evidence of continued injecting drug use after attaining sustained treatment-induced clearance of the hepatitis C virus: implications for reinfection","volume":"154","author":"Valerio","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.05.012_bib0150","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/infdis\/jis213","article-title":"The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design","volume":"205","author":"Vickerman","year":"2012","journal-title":"J. Infect. Dis."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616301181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616301181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T20:27:16Z","timestamp":1656620836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616301181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":30,"alternative-id":["S0376871616301181"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.05.012","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}